- Cannabix Technologies (BLO) will begin beta testing its marijuana breathalyzer with a private clinic in the Northwestern U.S.
- Beta testing will focus on training the device’s machine learning database, determining sensitivity ranges and usability
- The clinic is one of the top drug testing providers to employers in its state
- The company expects to deliver its version 3.0 THC Breath Analyzer prototype to the clinic in the coming weeks
- Cannabix Technologies develops marijuana breathalyzers for law enforcement and the workplace
- Cannabix Technologies (BLO) is up 7.24 per cent and is currently trading at C$1.63 per share
Cannabix Technologies (BLO) will begin beta testing its marijuana breathalyzer with a private clinic in the Northwestern U.S.
Cannabix’s THC Breath Analyzer allows for the quick, easy and non-invasive testing for recent use of THC, the psychoactive component of marijuana.
Beta testing will focus on training the device’s machine learning database, determining sensitivity ranges and usability.
The data will also help with identifying cross-reactivity of other substances with the study population.
Cannabix expects to deliver its version 3.0 THC Breath Analyzer prototype to the clinic in the coming weeks.
The clinic has a robust drug testing operation and is one of the top drug testing providers to employers in its state. It serves a diverse range of patients and focuses on private sector testing for alcohol and illicit drugs.
The clinic also has extensive experience beta testing new drug testing technologies, including oral swab devices which have been authorized for use in certain jurisdictions.
Studies have shown that breath is a better indicator of impairment than saliva and urine because THC is present in breath for only 1-3 hours, while it can be detected in other bodily fluids for days or even weeks after smoking. This short detection period in the breath aligns with the peak impairment window.
Cannabix and the clinic have entered into a non-disclosure agreement.
Cannabix Technologies develops marijuana breathalyzers for law enforcement and the workplace.
Cannabix Technologies (BLO) is up 7.24 per cent and is currently trading at C$1.63 per share as of 9:44 am ET.